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Abstract
Background: The nuclear lamina is a protein meshwork lining the inner nuclear membrane, which
contains a polymer of nuclear lamins associated with transmembrane proteins of the inner nuclear
membrane. The lamina is involved in nuclear structure, gene expression, and association of the
cytoplasmic cytoskeleton with the nucleus. We previously identified a group of 67 novel putative
nuclear envelope transmembrane proteins (NETs) in a large-scale proteomics analysis. Because
mutations in lamina proteins have been linked to several human diseases affecting skeletal muscle,
we examined NET expression during differentiation of C2C12 myoblasts. Our goal was to identify
new nuclear envelope and lamina components whose expression is coordinated with muscle
differentiation.
Results: Using transcriptional microarray analysis, we found that expression of 6 of the NETs
significantly increases during myoblast differentiation. We confirmed these results using
quantitative RT-PCR, and furthermore, found that all 6 NETs are expressed at high levels in adult
mouse skeletal muscle relative to 9 other tissues examined. Using epitope-tagged cDNAs, we
determined that the 5 NETs we could analyze (NETs 9, 25, 32, 37 and 39) all target to the nuclear
envelope in C2C12 cells. Furthermore, the 3 NETs that we could analyze by immunoblotting were
highly enriched in nuclear envelopes relative to microsomal membranes purified from mouse liver.
Database searches showed that 4 of the 6 up-regulated NETs contain regions of homology to
proteins previously linked to signaling.
Conclusion: This work identified 6 NETs that are predicted to have important functions in muscle
development and/or maintenance from their expression patterns during myoblast differentiation
and in mouse tissues. We confirmed that 5 of these NETs are authentic nuclear envelope proteins.
Four members of this group have potential signaling functions at the NE, based on their sequence
homologies.
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Background
The nuclear envelope (NE), which forms the boundary of
the nucleus in eukaryotic cells, compartmentalizes
nuclear metabolism and helps to organize nuclear struc-
ture (reviewed in refs. [1-3]). It contains an inner (INM)
and outer nuclear membrane (ONM) separated by the
perinuclear lumenal space and joined at nuclear pore
complexes (NPCs), giant supramolecular assemblies that
mediate molecular trafficking between the nucleus and
the cytosol (reviewed in refs. [4,5]). The ONM is continu-
ous with the peripheral ER and in large part, is function-
ally similar to the latter. In contrast, INM is lined by the
nuclear lamina, a meshwork containing a polymer of the
lamin intermediate filament proteins as well as other
more minor polypeptides, including transmembrane pro-
teins concentrated at the INM (reviewed in refs. [6,7]).
Mammals contain 4 major lamin subtypes: lamins A and
C, which are encoded by alternatively spliced transcripts
of the same gene, and lamins B1 and B2, which are prod-
ucts of separate genes (reviewed in refs. [6-9]). Lamins B1
and B2 are expressed in most somatic cells throughout
development, whereas lamins A/C usually are expressed
only at or following differentiation.
Genetic and cell biological studies indicate that the
nuclear lamina is a structural scaffold that provides
mechanical strength to the nucleus and helps to maintain
nuclear shape. The lamina also is involved in tethering
chromatin and the cytoplasmic cytoskeleton to the NE
(reviewed in refs. [10,11]), and mounting evidence impli-
cates the lamina in regulation of gene expression [7,12].
The importance of the lamina in cells is emphasized by
recent work showing that over 15 inherited human dis-
eases ("laminopathies") are caused by mutations in lam-
ina components (reviewed in refs. [7,12-14]). Many
laminopathies target specific tissues, most commonly
cells of skeletal muscle and heart, adipose tissue, or bone
and connective tissue, although progeroid syndromes
arising from mutations that target NE proteins affect
many cell types.
Whereas laminopathies most frequently are caused by
mutations in the gene for lamins A/C, human disorders
also can arise from mutations in certain transmembrane
proteins of the INM. These include emerin, which is
linked to Emery-Dreifuss muscular dystrophy, LBR, which
is associated with Pelger Huet Anomaly and Greenberg
skeletal dysplasia, and MAN1, which is linked to oste-
opoikilosis and melorheostosis. Diseases with the same
clinical symptoms can be caused by mutations in either
lamins or in INM proteins (e.g. mutations in either lamins
A/C or emerin can cause Emery-Dreifuss muscular dystro-
phy), emphasizing that some of these proteins have
closely linked functions [12,13].
A number of transmembrane proteins of the INM have
been connected to different facets of chromatin regulation
and NE function. For example, the INM protein LBR in
mammals binds to HP1 [15], which is involved in hetero-
chromatin formation. Moreover, the mammalian INM
proteins LAP2β, emerin, and MAN1 all contain a ~40
amino acid α-helical "LEM domain" [16]. The LEM
domain binds BAF, a DNA-binding protein that appears
to be involved in chromosome organization and nuclear
assembly (reviewed in ref. [7]). Moreover, multiple INM
proteins, including LEM domain proteins, have been
found to directly bind to transcriptional regulators
(reviewed in ref. [7]). Recently, the LEM protein MAN1
has been shown to attenuate TFG-β signaling due to its
direct interaction with Smad transcription factors
(reviewed in ref. [17]).
The lamina also has been linked to organization of the
cytoplasmic cytoskeleton. Pioneering work in C. elegans
identified NE transmembrane proteins involved in
anchoring the actin cytoskeleton to the NE, including the
lamin-interacting UNC-84 protein of the INM and the
actin-binding ANC-1 protein of the ONM [18]. Homolo-
gous proteins have been described in mammalian cells,
including Sun1 of the INM (homologous to UNC-84),
which interacts in the perinuclear space with an ONM
protein, nesprin 2 giant (homologous to ANC-1), which
contains an actin-binding domain [19-21]; reviewed in
ref. [11].
Conventional cell biological methods have been success-
ful in identifying ~15 transmembrane proteins (together
with their splice variants) that are concentrated at the NE.
We recently carried out a large-scale analysis of NE iso-
lated from rodent liver using MudPIT proteomics, and
identified an additional 67 novel putative nuclear enve-
lope transmembrane proteins (NETs) [22]. We found that
a randomly selected set of 8 of these proteins all target to
the NE of cultured cells when expressed by transfection as
epitope-tagged fusions [22], confirming that they are
authentic NETs and suggesting that most members of this
group will prove to be NE proteins.
Striated muscle is one of the tissues most commonly
affected by laminopathy mutations [12,13]. With the goal
of understanding this disease association, we have ana-
lyzed expression of the novel NET genes during differenti-
ation of the murine C2C12 skeletal myoblast cell line.
Extensive precedent from studies of tissue development
predicts that NETs up-regulated during myoblast differen-
tiation will be important for differentiation and/or for
muscle cell maintenance. From this analysis, we identified
6 NETs that are significantly up-regulated during myogen-
sis. We found that these NETs also are highly expressed in
mouse muscle, and confirmed that 5 of these are authen-BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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tic NE proteins. Based on their sequence homologies,
many of these proteins could have roles in signal trans-
duction at the NE.
Results
Changes in NET expression during C2C12 differentiation
We have examined the expression of the novel putative/
confirmed NETs in mouse C2C12 cells during differentia-
tion, as a means of identifying proteins with a potential
role in muscle development. C2C12 cells are an immor-
talized myoblast line derived from a stem cell ("satellite
cell") of adult skeletal muscle involved in muscle regener-
ation (reviewed in ref. [23]), which expresses the myo-
genic specification markers MyoD and Myf5. When
cultures are shifted to medium containing low serum, the
cells withdraw from the cell cycle and ~50–75% of the cell
population undergoes differentiation to form multinucle-
ated myotubes [23,24]. The remaining mononucleated
cells retain the potential for muscle differentiation upon
further culturing [25]. Differentiation of C2C12 cells into
muscle involves the induction of "late" myogenic tran-
scriptional regulatory factors including myogenin and
MEF2C, followed by expression of the cell cycle inhibitor
p21 and muscle-specific structural proteins including
components of myofilaments (e.g., myosin heavy chain
and troponins). We used Affymetrix DNA microarray
analysis to compare the transcript levels of the novel puta-
tive/confirmed NETs in proliferating C2C12 cells vs. dif-
ferentiated populations examined 6 days after shift to low
serum medium (Fig. 1). Of the 67 NETs described in our
proteomics analysis, 60 could be analyzed with the
Affymetrix Mouse Genome 430 v2.0 microarray chip
used. Additional File 1 provides an updated description of
the original 67 NETs identified in our proteomics analy-
sis, including homology regions identified by BLAST
searches of the most recent Pfam, Smart and NCBI COG
databases. It also lists the different probe-sets on the
Affymetrix 430 v2.0 chip that recognized each of the 60
NET genes detected, and the primers used for analysis of
certain transcripts by RT-PCR (described below).
A substantial fraction of the putative/confirmed NETs
showed significant changes in their transcript level (i.e.,
with a p-value < 0.05 and showing >~1.5-fold change,
dashed lines in Fig. 1) in differentiated C2C12 cultures, as
compared to proliferating cells (Fig. 1A). There was a sig-
nificant increase in the transcript level of 6 of the NETs
(NETs 9, 14a, 25, 32, 37 and 39), a significant decrease in
the level of 15 of the NETs, and no substantial change for
the rest. Many of the well-characterized lamina proteins
showed a significant decrease in their transcript level in
the differentiated C2C12 cultures, as compared to the pro-
liferating cells (Fig. 1B). Down-regulated transcripts
included those for the 3 lamin subtypes and for the trans-
membrane proteins nurim, LAP2, emerin and LBR. Con-
versely, there was a significant increase in the transcript
level of the transmembrane protein SUN1 (implicated in
anchoring of the actin cytoskeleton to the NE; see Back-
ground). The levels were not significantly changed for the
remaining proteins, including MAN1, LAP1B and LUMA.
As expected, the transcript level increased substantially for
several markers of terminal myogenic differentiation
including desmin (a muscle-specific intermediate fila-
ment protein), MEF2C and myogenin (Fig. 1C).
DNA microarray analysis of proliferating and differentiated  C2C12 cells Figure 1
DNA microarray analysis of proliferating and differ-
entiated C2C12 cells. Three undifferentiated (baseline) 
and 3 differentiated (experimental) microarray data sets 
were obtained from a total of 6 Affymetrix mouse genome 
430 2.0 GeneChips™ as described in Materials and Methods. 
Those genes for which the microarray data had a p-value < 
0.05 and where the change was ≥~1.5 fold, were deemed to 
"significantly" change. The NETs that met these two criteria 
were graphed. (A) up- or down-regulated NETs; (B) NE pro-
teins; (C) muscle differentiation markers. Asterisks indicate 
previously validated NETs [22]. The dash lines indicate a 1.5 
fold change. Abbreviations: Lamin A associated peptide 2 
(LAP2) and Myocyte enhancing factor 2C (MEF 2C). Syno-
nym: SUN1 (Unc84a). NET14a is one of the two alternatively 
spliced transcripts appearing in the new gene annotations, for 
the originally described NET14.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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To confirm and extend the results of the microarray anal-
ysis, we analyzed a number of the transcripts by quantita-
tive real time RT-PCR. This technique provides a more
accurate representation of changes in the level of specific
transcripts in the differentiated vs. proliferating C2C12
cells than the microarray analysis, since the RT-PCR signal
is linear over a broad concentration range [26,27], as val-
idated by our serial dilution studies with various samples
(data not shown). We analyzed all 6 of the up-regulated
NETs and a sample of 4 of the down-regulated NETs (Fig.
2A). For all of the transcripts examined, the results
obtained with the RT-PCR reflected the same up- and
down-regulation trends as revealed by the microarray data
(Fig. 2A, solid bars, RT-PCR; lightly shaded bars, microar-
ray results taken from Fig. 1; and data not shown),
although the magnitude of some of the changes was dif-
ferent. RT-PCR revealed that the levels of NET14a, NET37
and NET39 transcripts increased substantially more than
seen by microarray analysis (NET37, 7-fold increase;
NET39, 39.5-fold increase; NET14a, 3-fold increase; Fig.
2A), whereas the level of NET53 decreased less by RT-PCR
analysis (~2-fold decrease) than seen by microarray. The
massive increase in the level of NET39 transcript during
C2C12 differentiation indicates a very strong "off/on"
control for this gene during terminal myogenesis.
We also examined 4 NETs that showed no significant
changes in the microarray analysis, NETs 4, 26, 31 and 56,
and found that these transcripts similarly showed no sig-
nificant changes in RT-PCR (data not shown). As controls,
we analyzed transcripts for marker proteins of the NE (Fig.
2B) and of muscle (Fig. 2C). As observed with the NETs,
the RT-PCR results were consistent with the microarray
data, and some of the transcripts for up-regulated markers
(i.e., myogenin and MEF2C) underwent greater increases
than observed with the microarray.
Since both transcriptional and posttranscriptional mecha-
nisms can regulate gene expression, we decided to exam-
ine changes in the protein levels of several NETs and
control polypeptides during C2C12 differentiation (Fig.
3). These results were compared to the changes in tran-
script levels as measured by RT-PCR (Fig. 2). For this anal-
ysis we prepared affinity-purified anti-peptide antibodies
against NETs 25, 32 and 37, which recognized their cog-
nate antigens in isolated mouse liver NEs by immunoblot-
ting (see Fig. 7 below). However, only 1 of these
antibodies (anti-NET25) was sufficiently strong to detect
the antigen in whole lysates of C2C12 cells, where the
antigens are substantially less enriched than in isolated
NEs (Fig. 3). In addition, the antibodies were not useful
for immunofluorescence localization. Several well-charac-
terized NE markers (lamins A and C, lamin B1, emerin)
and the muscle intermediate filament desmin were ana-
lyzed in parallel. We normalized the protein levels to his-
tone H2B, which is proportional to the amount of nuclear
DNA and thus to the number of nuclei. H2B levels were
closely correlated with the total protein amount in the
samples (data not shown).
In all cases examined, we found that the proteins
increased to significantly higher levels than predicted by
the transcript levels (Fig. 3). Whereas the transcript levels
Validation and extension of microarray analysis by quantita- tive/real-time PCR Figure 2
Validation and extension of microarray analysis by 
quantitative/real-time PCR. Primer sets (see Additional 
File 1) were designed to target the Affymetrix probe set 
region of the selected genes and to amplify the region across 
exon-exon junctions whenever possible. Quantitative PCR 
was performed as described in Materials and Methods. 
Shown is the mean of all signal values obtained from 6 inde-
pendent RNA samples. (A) novel NETs; (B) NE markers pro-
teins; (C) muscle differentiation markers. The error bars 
indicate the standard deviation. Gray columns indicate the 
fold changes obtained in the microarray analysis, taken from 
Fig. 1.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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of lamins A/C, lamin B1 and emerin decreased 1.5-6-fold
during C2C12 differentiation, the protein levels increased
up to 2.4-fold. NET25 protein increased ~9.4-fold (as
compared to ~1.5-fold transcript increase), and desmin
protein increased ~5.4-fold (as compared to ~3-fold tran-
script increase. These relative increases in protein
amounts, as compared to transcript levels, could result
from multiple posttranscriptional mechanisms, including
an increase in protein half-life in the differentiated cells,
an increase in translation rate, and the cessation of protein
dilution by cell growth and division. Irregardless, the pos-
itive correlation between increase in transcript and pro-
tein levels seen for NET25 and desmin suggest that most
or all of the NETs that are transcriptionally up-regulated
during C2C12 differentiation will increase at the protein
level as well. We predict that the largest increases will
occur for NETs14a, 37, and 39, which show the greatest
transcript increases.
NET transcript expression in adult mouse tissues
To examine whether the 6 NETs whose transcripts are up-
regulated during C2C12 myoblast differentiation are
expressed highly in skeletal muscle relative to other tis-
sues, we carried out quantitative RT-PCR on 10 adult
mouse tissues: brain, thymus, heart, lung, liver, spleen,
stomach, intestine and kidney and hindlimb skeletal mus-
cle (Fig. 5). As a benchmark for interpreting these results,
we used RT-PCR to compare the transcript levels of
desmin and several well-characterized NE markers,
including lamins and NE transmembrane proteins,
among the 10 mouse tissues (Fig. 4).
Consistent with its known muscle-specific expression, the
desmin transcript appeared at a high level in heart and
muscle (consisting mainly of striated muscle) and at low
levels in stomach and intestine, which contain layers of
smooth muscle cells on their outer surfaces. The transcript
abundance of the NE markers we tested varied widely
among the different tissues. However, many of the mark-
ers were expressed at significantly higher levels in 1–3 of
the tissues than in the others (i.e., at >2-fold higher levels
than in the remaining tissues) (Fig. 4). Selectively high
expression was seen for lamin C in heart, lamin B2 in
intestine, LBR in spleen, emerin in heart and skeletal mus-
cle, and MAN1 in skeletal muscle.
Our analysis of the mouse tissues revealed that all 6 of the
NETs up-regulated in C2C12 differentiation were
expressed at relatively high levels in skeletal muscle (Fig.
5). Five of the 6 NETs (NETs 9, 14a, 25, 37 and 39) were
expressed at higher levels in skeletal muscle than in any of
the other tissues examined, and the 6th  (NET32) was
expressed at its second highest level (~50% of the maxi-
mum) in skeletal muscle. The NETs can be further
grouped according to two general types of expression pat-
terns among the set of tissues: (a) NETs 9 and 32 showed
relatively high expression (>20% of the maximum level)
in the majority of tissues; (b) NETs 14a, 25, 37 and 39
were expressed with strong preference in skeletal muscle
(>5-fold higher than in most or all other tissues),
although NETs14a, 37, and 39 also were expressed at sub-
stantial levels in heart relative to the remaining tissues.
The specific cell types where NET expression takes place in
the "low expressing" tissues remain to be determined.
These conceivably could be relatively minor cell popula-
tions (e.g. connective tissue or endothelial cells) in which
the expression levels are much higher than the tissue aver-
age.
In addition to analyzing adult mouse tissues, we exam-
ined the transcript levels for the marker proteins and the
6 NETs at embryonic day 17 (E17) and at postnatal day 7
(P7), as compared to adult (Additional Files 2 and 3).
Although organogenesis is essentially completed at E17 in
all of the tissues examined except for brain, cell prolifera-
tion continues (particularly at P7) and the tissues undergo
progressive functional adaptation at the 2 later times. The
6 NETs were expressed at the highest levels at P7 and/or
Immunoblot analysis of marker proteins and NET25 during  C2C12 differentiation Figure 3
Immunoblot analysis of marker proteins and NET25 
during C2C12 differentiation. Total proteins from 
C2C12 cultures harvested either on day 0 (undifferentiated 
cells) and at day 6 after induction of differentiation were 
examined by immunoblot analysis and quantification as 
described in Materials and Methods). Shown are representa-
tive images of immunoblots and the calculated fold changes 
from day 0 to day 6.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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adult, as compared to E17, in almost all of the tissues
examined (Additional File 3). A noteworthy exception
was NET37, which was expressed at a greater than 10-fold
higher level in brain at E17 when neurogenesis is occur-
ring, as compared to the later times. Furthermore, expres-
sion of the 6 NETs in heart and skeletal muscle occurred
at substantially higher levels in adult tissues (up to 15-
fold) than in tissues at E17 and P7. NET39 and NET14a
showed the widest range of expression levels among the
different tissues examined, indicating that these genes
have the most stringent off/on control (Additional File 4).
When antibodies of sufficient sensitivity become availa-
ble, it will be important to directly measure protein levels
of NETs across various tissues, since the protein levels may
not precisely correspond to the NET transcript levels
measured here (see discussion in above section).
Localization of NETs to the NE
We next analyzed whether the 6 NETs that are transcrip-
tionally up-regulated during C2C12 differentiation are
bona fide NE proteins, as determined by their ability to tar-
get to the NE when ectopically expressed. For our analysis,
Expression of NE marker proteins and desmin in 10 tissues of adult mouse Figure 4
Expression of NE marker proteins and desmin in 10 tissues of adult mouse. Transcript levels of selected lamina pro-
teins were measured by quantitative real-time PCR in ten adult C129 mouse organs or tissues. All signal values were normal-
ized to peptidylprolyl isomerase A (Ppia), which was the most consistent reference transcript among four reference transcripts 
tested across all mouse tissues. The Y-axis indicates the expression level of a gene relative to the highest value (normalized to 
100%) in the same tissue. The error bars indicate the standard deviation. The raw data used for preparation of this figure was 
derived from Additional File 2.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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Expression of NETs up-regulated in C2C12 differentiation in 10 tissues of adult mouse Figure 5
Expression of NETs up-regulated in C2C12 differentiation in 10 tissues of adult mouse. Gene expression levels of 
the up-regulated NETs during C2C12 differentiation were measured by quantitative/real-time PCR in ten adult C129 mouse 
tissues. All signal values were normalized to peptidylprolyl isomerase A (Ppia) as in Fig. 4. The left Y-axis indicates the expres-
sion level of a gene relative to the highest value (normalized to 100%) in the same tissue. The error bars indicate the standard 
deviation. The raw data used for preparation of this figure was derived from Additional File 3.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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we constructed cDNAs encoding full-length NETs with a
V5 epitope tag fused to their C-terminus, and transiently
transfected these cDNAs into proliferating C2C12 cells.
Cells either were maintained in normal growth medium
(Fig. 6A), or were shifted to low serum-containing
medium for 6 days after transfection to induce the forma-
tion of myotubes (Fig. 6B). They then were fixed and proc-
essed for immunofluorescence localization of the
transfected proteins, either with (+ T) or without (-T) pre-
extraction of cells with buffer containing Triton X-100
before fixation. As seen with the previously characterized
NE marker LAP2β (Fig. 6), when NE transmembrane pro-
teins are over-expressed in cultured cells, the proteins
become concentrated at the NE but also appear in the
peripheral ER, presumably resulting from saturation of
NE binding sites (e.g., Ref. [22]. Triton pre-extraction pref-
erentially solubilizes a portion of the peripheral ER pool,
whereas the NE form typically remains associated with
Triton-insoluble NE substructures (Fig. 6, LAP2β panels).
We were able to analyze the expression of all of the NETs
except for NET14a, which was not detectable in a signifi-
cant number of C2C12 cells at any time point after trans-
fection.
In proliferating C2C12 cells, NETs 9, 25, 32, 37 and 39 all
targeted to the NE and showed elevated nuclear rim stain-
ing relative to adjacent cytoplasmic areas (Fig. 6A). This
contrasted with the localization pattern of epitope-tagged
calnexin (Cnx), a marker protein for the ER [28], which
showed no preferential nuclear rim staining (Fig. 6A). The
NE-associated pool of NETs was preferentially retained at
the nuclear rim after Triton extraction, whereas a substan-
tial portion of the cytoplasmic pool of the NETs (Fig. 6A),
and all of the transfected calnexin (data not shown), was
removed. All of the exogenously expressed NETs except
for NET39 clearly targeted to the NE in differentiated
myotubes (Fig. 6B); however, the cytoplasmic pool of the
overexpressed proteins in the myotubes was largely insen-
sitive to extraction by Triton. NET39 expressed in myo-
tubes only occasionally showed elevated nuclear rim
labeling relative to the peripheral ER, in contrast to the
other NETs. However, NE-localized NET39 in myotubes
may be obscured by the substantial cytoplasmic pool that
accumulates during the longer expression times used in
the myotube experiments. Consistent with our findings
with C2C12 myoblasts, we previously found that NET39
targets to the NE of COS7 and HeLa cells in a Triton-resist-
ant form [22]. In C2C12 cells examined without Triton
pre-extraction, NETs 9, 32 and 39 typically showed less
intense nuclear rim labeling than NETs 25 and 37 (as
exemplified by the images presented in Fig. 6), which
could reflect lower numbers of binding sites at the NE for
the former proteins.
We next used the antibodies we obtained to NETs 25, 32
and 37, which recognize the proteins by immunoblotting,
to examine the relative concentration of these proteins in
isolated NEs and MMs of mouse liver (Fig. 7). MMs from
liver are enriched rough and smooth ER membrane and
devoid of NE components [29]. We normalized the signal
in the two fractions to the phospholipid content in each
sample. We detected specific antigens at the predicted
molecular weights for NETs 25, 32 and 37 in the NE frac-
tion, and found that the antigens were highly enriched in
NEs as compared to MMs. NETs 25 and 37 were not
detectable in MMs under these conditions, similar to
emerin (Fig. 7), even when 3-fold more MMs were ana-
lyzed by immunoblotting than analyzed in Fig. 7 (data
not shown). Based on the lower limit of detection, we esti-
mate that these proteins are >~90-fold enriched in NEs as
compared to MMs. On the other hand, NET32 was detect-
able in MMs, and was 16-fold enriched in NEs as com-
pared to MMs (Fig. 7). In contrast to NET32, the ER
resident folding chaperone calnexin had virtually identi-
cal concentrations in NEs and MMs. The NE enrichment
of these 3 NETs extends the analysis with transfected
epitope-tagged proteins, and strongly suggests NE-specific
functions for these proteins. Nonetheless the presence of
NET32 in the MM fraction, albeit at a substantially lower
concentration than in the NE, suggests that it may have
additional functions in the peripheral ER.
Discussion
Identification and characterization of NETs up-regulated 
in C2C12 differentiation
We used DNA microarray analysis and quantitative RT-
PCR to compare the transcript levels of novel NETs iden-
tified in our proteomics analysis [22] in samples from
proliferating and differentiated murine C2C12 myoblasts.
We found that 6 NETs were significantly up-regulated, and
15 others significantly down-regulated, in differentiated
cultures. Based on precedent from studies of tissue devel-
opment, the up-regulated NETs are likely to have a role in
muscle formation and/or maintenance, and NETs that are
down-regulated could antagonize these processes.
In agreement with this hypothesis, we found that the 6
up-regulated NET transcripts were expressed highly in
skeletal muscle of adult mouse, as compared to 9 other
mouse tissues. Of these, NETs 14a, 25, 37 and 39 were
expressed with strong preference in skeletal muscle (i.e.,
>5-fold higher than in most or all other tissues), and NETs
14a, 37 and 39 were also expressed at a substantial level
in heart. NETs 9 and 14a showed a broader expression
profile, but transcript levels in muscle were still signifi-
cantly above the average. This confirms and extends our
earlier conclusion that NETs have tissue-selective expres-
sion patterns [30]. Western blot analysis showed a posi-
tive correlation between transcript and protein levels forBMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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Nuclear envelope targeting of NETs up-regulated in C2C12 differentiation Figure 6
Nuclear envelope targeting of NETs up-regulated in C2C12 differentiation. V5 epitope tagged NETs, LAP2β and cal-
nexin (Cnx) were transiently transfected into C2C12 cells. Cell were left untreated (- T) or extracted with 1% Triton X-100 (+ 
T) before fixation and immunofluorescence staining. Shown are representative images from (A) undifferentiated C2C12 cells, 
(B) differentiated C2C12 cells. All epitope-tagged calnexin was removed by Triton X-100 pre-extraction (not shown). Scale 
bar: 20 µm.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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NET25 and several markers of C2C12 differentiation.
While changes in transcript levels are not always reflected
in changes of protein levels, this result suggests that other
transcriptionally up-regulated NETs probably increase at
the protein level.
We found that NETs 9, 25, 32, 37 and 39, when expressed
as epitope-tagged proteins in C2C12 myoblasts, were con-
centrated at the NE in a Triton-resistant manner, indicat-
ing that they are authentic NE transmembrane proteins.
However, the fraction of ectopically expressed protein that
localized to the NE vs. the peripheral ER varied between
different NETs as well as between individual cells in a
transfected population. Based on the model that accumu-
lation of membrane proteins at the NE is limited mainly
by binding [31], this variability may be due to different
numbers of binding sites for each NET at the NE, or due
to different levels of protein over-expression.
Supporting the results of our NE targeting studies in
C2C12 cells, immunoblot analysis of subcellular fractions
from mouse liver showed that NETs 25, 32 and 37 were
highly enriched in the NE as compared to the MM. NETs
25 and 37 were >~90-fold more concentrated in NEs than
in MMs, similar to the NE marker emerin. In contrast,
NET32 was only ~16-fold more concentrated in NEs.
Since the surface area of the peripheral ER is estimated to
be ~100-fold greater than that of the NE in hepatocytes
[32], p 661), a major fraction of NET32 apparently resides
in the peripheral ER in this cell type. Our results also indi-
cate that localization of proteins to the NE is not an "all or
none" phenomenon. Furthermore, the partitioning of dif-
ferent proteins between NE and the peripheral ER may
show cell type-specific differences. Thus, NET32 may have
functions in both the NE and the peripheral ER, at least in
hepatocytes.
Potential functions of up-regulated NETs
Standard BLAST searches against publicly available data-
bases (Additional File 1) revealed that 4 of the 6 NETs up-
regulated in C2C12 differentiation (NETs 25, 32, 37 and
39) contain regions with homology to proteins that have
been linked to signal transduction. In addition, the pre-
dicted extralumenal region of NET14a contains a WD40
domain, which typically serves as a protein interaction
interface [33].
A model depicting the predicted membrane topologies
and homology domains of the 6 NETs upregulated in
C2C12 differentiation is presented in Fig. 8. The proteins
Relative abundance of NETs in isolated nuclear envelopes and microsomal membranes of liver Figure 7
Relative abundance of NETs in isolated nuclear envelopes and microsomal membranes of liver. Mouse liver NE 
and MM fractions were analyzed by immunoblotting with antibodies against NET25, NET32, and NET37 as indicated above 
each image. Control blots with anti-emerin and anti-calnexin antibodies, as well as a representative Ponceau Red stain of one of 
the membranes used in these experiments are shown on the right. Positions of the target proteins are indicated by black 
arrowheads. Labeling of these bands was strongly diminished by pre-incubating the antibodies with the cognate peptides (data 
not shown), whereas labeling of nonspecific bands was not. A nonspecific in the microsomal lane of the anti-NET37 blot is indi-
cated by an asterisk. Where feasible, signal intensities normalized to the signal in the NE lanes are shown below each mem-
brane.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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are predicted to have 1–4 transmembrane regions and
contain one or two sizable extralumenal domains. NET9,
also termed LULL1 [34], in addition has a substantial
lumenal domain that interacts with torsinA [34]. Whether
these proteins reside in the inner or outer nuclear mem-
brane (or both) needs to be resolved by immunoelectron
microscopy.
NET25, identified independently as LEM2 [35], shows
homology to the first ~770 residues of MAN1 [35], a fac-
tor shown to regulate TGF-β signaling (reviewed in ref.
[17]). The regions of homology include the N-terminal
LEM domain [16], two predicted transmembrane
sequences and a winged helix domain that binds DNA
[36]. However, NET25 lacks the C-terminal Smad-tran-
scription factor binding domain present in MAN1 [37-
40]. Nonetheless, we found that the tissue expression pro-
files of NET25 and MAN1 are very similar, as both genes
have the highest expression in skeletal muscle. Thus, these
proteins may have partially overlapping functions.
Almost all of NET32 (Fig. 8), including the two predicted
membrane-spanning regions, spans the complete length
of the "SPFH" consensus sequence (reviewed in refs.
[41,42]). Although the functions of the SPFH domain
remain unclear, multiple proteins containing this region
occur in sphingolipid-enriched "lipid rafts", which are
buoyant membrane derivatives identified by extraction
with nonionic detergent. Raft fractions are thought to rep-
resent membrane microdomains that mediate signaling
events (reviewed in refs. [43-45]). Analogous to func-
tional models proposed for other SPFH domain proteins
[41,42], NET32 might be involved in the organization of
lipid microdomains at the NE involved in signaling. It is
plausible that these hypothetical NE microdomains con-
tain sphingolipids, since there are several reports describ-
ing sphingolipids and associated enzymes in the NE (e.g.,
Refs. [46-48].
The predicted nucleoplasmic/cytosolic domain of NET37
is homologous to family 31 glycosidases (Fig. 8). One
potential substrate for the predicted extralumenal glycosi-
dase domain of NET37 is O-linked N-acetylglucosamine
(O-linked GlcNAc), which is suggested to have a regula-
tory role akin to phosphorylation (reviewed in refs.
[49,50]). A second potential substrate of NET37 are gly-
cosphingolipids, a fraction of which faces the cytosol in
the peripheral ER (reviewed in ref. [51]). Carbohydrate
removal from glycosphingolipids generates ceramide, a
signaling lipid that plays key roles in differentiation and
apoptosis by activating downstream kinases/phos-
phatases (reviewed in refs. [52,53]). Thus, as either a gly-
cosidase or glycosphingolipid hydrolase, NET37 could
play a role in myoblast differentiation.
NET39 has homology to phosphatidic acid phosphatase
type 2 in the region that includes its 2 predicted mem-
brane-spanning segments (Fig. 8). If NET39 were a phos-
pholipid phosphatase (reviewed in refs. [54,55]), it could
produce the second messenger diacylglycerol, or might
attenuate the levels of signaling lipids that enhance cell
proliferation, such as sphingosine-1-phosphate or lyso-
phosphatidic acid (reviewed in refs. [53,56]). It is intrigu-
ing that the actions of sphingosine-1-phosphate and
lysophosphatidic acid (which hypothetically could be
degraded by NET39) usually antagonize the actions of
ceramide (which hypothetically could be up-regulated by
NET37). Thus, the activities of NET37 and NET39, the
most highly up-regulated of any of the NETs in C2C12 dif-
ferentiation, could be coordinately involved in myogene-
sis by attenuating cell proliferation signals and enhancing
differentiation signals. Determining biochemical activi-
ties and substrate specificities of NETs 37 and 39 will be
key to elucidating these questions.
Conclusion
We have identified 6 novel NETs with predicted roles in
myoblast differentiation and/or muscle maintenance, by
analyzing changes in NET expression during C2C12 dif-
ferentiation, and by comparing expression levels among
various adult tissues. Five of these were confirmed to be
authentic NE proteins, and 4 have homologies to proteins
implicated in signaling. We expect that further analysis of
Model depicting membrane topologies and homologies of  NETs up-regulated in C2C12 differentiation Figure 8
Model depicting membrane topologies and homolo-
gies of NETs up-regulated in C2C12 differentiation. 
NET9 (502 residues), NET14a (312 residues), NET25 (511 
residues), NET32 (340 residues), NET37 (716 residues) and 
NET39 (271 residues) are drawn to scale. Regions with 
homology to known proteins are color coded as indicated. 
Transmembrane regions, indicated in black, were predicted 
using the internet based TMPred and TMHMM servers. The 
phospholipid bilayer is indicated by a hatched rectangle.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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these proteins will shed light on the newly emerging func-
tions of the NE in signal transduction and gene expres-
sion.
Methods
Plasmid construction
To create expression vectors encoding C-terminally V5-
tagged fusion proteins, cDNA sequences were PCR ampli-
fied and cloned into pcDNA 3.1 D/V5-His-TOPO (Invitro-
gen, Carlsbad, CA). NET9, NET32, and NET39 DNA
sequences were PCR amplified from the cDNA clones
ATCC 10159451, MGC-27952 and MGC-28994 respec-
tively. The primers for PCR amplification of these were
NET9 Fwd: CACCATGTCCCAAAGTCTGAAGAGCCA,
NET9 Rev: CAAAAGGCAGCCTCGCTCTTC,
NET32 Fwd: CACCATGGCTCAGTTGGGAGCTGTTG,
NET32 Rev: GTTCTCCTTTGTGGGTGCCTC,
NET39 Fwd: CACCATGCCAGCTTCCCAGAGCCG, and
NET39 Rev: CCAGGCAGAGATGAGCATCTG. NET14a,
NET25, NET37 and calnexin were PCR-amplified from
bulk cDNA that we prepared from RNA extracted from
C2C12 cells using Transcriptor First Strand cDNA Synthe-
sis Kit™ (Roche Diagnostics, Alameda, CA). The primers
for PCR amplification were
NET14a Fwd: CACCATGGCTACAGAAATTGGCTCT,
NET14a Rev: CACAGTAGATAATAAAAAGGAATAACG,
NET25 Fwd: CACCATGGCCGGCCTGTCGGAC,
NET25 Rev: TCGCTCTGAATCAGAGAAAGAGGA,
NET37 Fwd: CACCATGTCCCAGAACCTTCAGGAG,
NET37 Rev: GGACGCCCAGGTAAAGTAGGC,
Cnx Fwd: CACCATGGAAGGGAAGTGGTTACTG, and
Cnx Rev: CTCTCTTCGTGGCTTTCTGTT. NET14b cDNA
(WDC146-EGFP) was a kind gift of Dr. Akiko Sakai
(Okayama Univ., Okayama, Japan). Rat LAP2β cDNA was
previously described [22].
Antibodies
Anti-peptide antibodies to NETs were prepared by immu-
nization of rabbits with synthetic peptides coupled to pre-
activated keyhole limpet hemocyanin (KLH, Imject™,
Pierce Biotechnology, Rockford, IL). Each rabbit was
injected with a mixture of 2–3 different peptides derived
from the same NET, comprising the following sequences
(with each peptide containing an N-or C-terminally
added cysteine for conjugation to KLH): NET25, residues
49–59 and 63–81; NET32, residues 262–277, 311–325
and 326–340; and NET37, residues 1–15, 18–32 and
322–336. For affinity purification, each peptide was con-
jugated to CNBr-activated Separose at a concentration of
0.5 mg peptide/ml beads. Typically, antibodies were affin-
ity-purified using a column containing a mixture of the 2–
3 peptides used to immunize the animal. Antibodies were
eluted from the affinity columns with 4 M MgCl2, and
were dialyzed against PBS. Polyclonal antibodies to lam-
ins A/C and lamin B1 were prepared in rabbits using the
pertinent recombinant proteins, and affinity purified
using columns coupled with recombinant proteins. Anti-
bodies to the following antigens were obtained from com-
mercial sources: V5 epitope tag (mouse monoclonal,
Invitrogen); desmin and emerin (mouse monoclonal,
Novocastra, UK).
Cell culture
C2C12 myoblasts (ATCC # CRL-1772) were grown in
Dulbecco's MEM supplemented with 20% FCS, 100 U/ml
penicillin, and 100 µg/ml streptomycin. To induce myob-
last differentiation [57], 5 × 105 C2C12 cells were seeded
into a 10 cm, gelatin-coated petri dish. 16 h later, cells
were shifted into "low serum" medium consisting of Dul-
becco's MEM supplemented with 2% horse serum and
antibiotics. This time point was termed "day 0". Multi-
nucleated myotubes could be seen by day 3, and increased
in number and size by days 5–6. Typically, at least 50% of
the nuclei were in multinucleated cells by day 6, the stand-
ard time point used for the differentiation experiments.
Transient transfection of C2C12 cells
C2C12 cells were seeded in 6-well microtiter plates con-
taining gelatin-coated glass coverslips at 1 × 105 cells/well
and allowed to grow for 16 h. Prior to transfection, the
growth media containing 20% FCS was removed from
cells and replaced with Opti-MEM™ (Invitrogen). cDNA
expression plasmids (1µg/well) were transiently trans-
fected into cells using Lipofectamine 2000™ (Invitrogen)
at 1:3 ratio (DNA [µg] vs. Lipofectamine [µl]) according to
the manufacturer's instructions. The transfection mix was
removed from cells 6 hours later and either replaced with
the high-serum growth medium to maintain cell prolifer-
ation, or with the low-serum media to induce cell differ-
entiation. Proliferating cell cultures were maintained for
another 18 to 36 h, whereas differentiated cells cultures
were maintained to day 6, and immunofluorescence
localization was carried out (below paragraph).BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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Immunofluorescence microscopy
Cells were fixed with 4% paraformaldehyde in PBS for 5
minutes at RT, either with or without pre-extraction with
Triton X-100 before fixation. For Triton pre-extraction,
cells were rinsed once with PBS and then extracted with
1% Triton X-100 in 10 mM Tris-HCl pH 7.5, 1.5 mM
MgCl2 and 2 mM CaCl2 for 30 seconds at RT. Following
fixation, cells were treated with 0.5% Triton X-100 in PBS
and then incubated for 1 h with a mouse monoclonal
antibody against the V5-epitope tag, followed by washing
in PBS and incubation for 1h with FITC-conjugated goat-
anti-mouse secondary antibody. Chromosomal DNA was
stained with TOPRO-3 (Invitrogen, Carlsbad, CA). The
stained cells on cover slips were subsequently mounted in
Gel Mount™ (Biomeda, Foster City, CA) and sealed with
Clarion™ (Biomeda). Cell images were taken with the Bio-
Rad/Zeiss MRC1024 laser scanning confocal microscope
and analyzed by LaserSharp 2000™ software (Bio-Rad).
Images were pseudo-colorized and merged with Adobe
Photoshop CS™.
RNA preparation
To extract RNA from C2C12 cells, proliferating or differ-
entiated cultures grown on 10-cm petri dishes were rinsed
once with PBS and directly lysed in 1 ml of Trizol™ (Invit-
rogen) following the manufacturer's instructions. RNA
samples were further treated with TURBO DNase™
(Ambion, Inc., Austin, TX) and purified by RNeasy Total
RNA Isolation Kit™ (Qiagen, Valencia, CA). RNA purity
was tested by spectrophotometry, and RNA integrity was
verified by agarose gel electrophoresis to visualize ribos-
omal RNA. To limit variance in the microarray experi-
ments, each RNA sample that was analyzed was pooled
from 3 separate culture plates that were grown at the same
time, and 3 such RNA pools prepared from cultures set up
at sequential one-day intervals were further combined. To
extract RNA from mouse tissues, the 10 tissues or organs
indicated were surgically removed from C129 mice on
embryonic day 17 (E17), post-natal day 7 (P7) or ~10
week old mice (adult). Care was taken to remove fat from
hindlimb skeletal muscle. Upon removal, tissues were
immediately immersed in RNA Later™ (Ambion, Inc.,
Austin, TX) and stored at -80°C to preserve RNA integrity.
Tissues or organs from 3–4 mice were pooled and homog-
enized in a hand-held homogenizer. RNA samples were
extracted and purified as described above.
DNA microarray analysis
DNA microarray hybridization was carried out by the TSRI
DNA microarray core facility [58]. Briefly, 5 µg of total
RNA were used to synthesize cDNA that was then used as
a template to generate biotinylated cRNA. cRNA was frag-
mented and hybridized to the Affymetrix GeneChip
Mouse Genome 430 2.0™ array (Affymetrix, Santa Clara,
CA), which allows analysis of over 39,000 transcripts
selected from GenBank, dbEST, and RefSeq. The probe set
for each gene on this microarray chip contains 11 perfectly
matched probes and 11 control probes with a 1 bp-mis-
match; moreover, some genes are represented by multiple
probe sets (Additional File 1). The arrays were then
washed and scanned with a laser scanner, and images
were analyzed by using Affymetrix Microarray SuiteVer-
sion 5.0™ (MAS 5.0; Affymetrix). The raw data of microar-
ray signal values were deposited in Gene Expression
Omnibus (GEO accession #GSE4694). Three different
RNA samples (see above) from proliferating and from dif-
ferentiated C2C12 cells were individually analyzed (6
microarrays total). The data were further normalized by
GCRMA [59] to eliminate probe level anomaly, and were
subjected to a Bayesian regularized t-test [60], comparing
proliferating cells ("baseline") and differentiated cells
("experimental"), to obtain a global false discovery rate
measurement and confidence level assessment, which is
indicated as a p-value for the significance of expression
changes for each probe set. A list of probe sets used to
measure NET expression level is provided in Additional
File 1. The expression change was calculated by dividing
the experimental (differentiated cells) signal values by the
baseline (proliferating cells) values for up-regulated
genes, and vice versa for down-regulated genes. Only data
from probe sets with a p-value of less than 0.05 in the reg-
ularized t-test were deemed "significant" and were used to
calculate the average expression change of NETs.
Quantitative real-time PCR
Quantitative real-time PCR was performed using a Light-
Cycler 2.0 thermal cycler system according to the manu-
facturer's instructions (Roche Diagnostics). RT-PCR
primers were designed to target the sequences close to
Affymetrix probe regions and the sequences across the
exon-exon junction when it was possible (Additional File
1). 2 µg of total RNA was first reverse-transcribed to cDNA
using Transcriptor First Strand cDNA Synthesis Kit™
(Roche Diagnostics). The cDNA sample was then used to
measure expression level of a gene. The targeted gene was
amplified using LightCycler FastStart DNA MasterPLUS
SYBR Green I™ (Roche Diagnostics) with a Touch-Down
PCR protocol, where annealing temperature was ramped
down from 68°C to 55°C to target a broad range of probe
annealing temperatures. A standard curve that was used to
correct different amplification efficiencies was generated
for each gene using a dilution series of cDNA prepared
from C2C12 total RNA. Two housekeeping genes, Hprt
and Ppia, were chosen for "Reference" transcripts in every
quantitative PCR run because both genes had consistent
expression levels across all tested samples. The "Calibra-
tor", a cDNA sample prepared from C2C12 total RNA in
bulk, was also included in each PCR run to correct vari-
ances among reagents and thermocycler runs.BMC Cell Biology 2006, 7:38 http://www.biomedcentral.com/1471-2121/7/38
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Immunoblot analysis
To quantify levels of NE proteins and desmin at day 0 and
day 6 after differentiation, 3 different C2C12 differentia-
tion experiments conducted on separate days were exam-
ined. Total cell protein was harvested on day 0 and day 6
after induction of differentiation, and equal amounts of
total protein from each sample were loaded on SDS gels.
Proteins were separated by electrophoresis, transferred to
a nitrocellulose membrane, and subjected to immunoblot
analysis. The analysis was performed using primary anti-
bodies against lamins A and C, lamin B1, NET25, emerin,
histone H2B and desmin, and horseradish peroxidase-
conjugated secondary antibodies. Proteins were detected
by SuperSignal West Pico™ (Pierce). X-ray films were
scanned on Bio-Rad GS-800 Calibrated Densitometer
(Bio-Rad, Hercules, CA). The intensities of the corre-
sponding protein bands were quantified by QuantityOne
software (Bio-Rad). Similar methods were used to com-
pare the concentrations of NETs in isolated NEs and MMs.
Subcellular fractionation of mouse liver
Mouse liver NEs were isolated as described [61], and
mouse liver MMs were prepared as before [22]. The anal-
ysis in Fig. 7 involved NEs that were pre-extracted with 0.5
M NaCl to remove most chromatin contamination [61].
Colorimetric determination of phospholipids
Phospholipids in mouse liver NE and microsomal mem-
brane (MM) fractions were determined using a miniatur-
ized method based on the complex formation between
phospholipids and ammonium thiocyanate [62]. Briefly,
20  µl of NEs or microsomal membranes (MMs) were
extracted with 400 µl chloroform: methanol (2 : 1) and
concentrated. Samples were diluted with chloroform to a
total volume of 150 µl and mixed with an equal volume
of ammonium thiocyanate. The amount of water insolu-
ble complex was determined spectrophotometrically at a
wavelength of 460 nm. Phospholipid concentrations were
determined using a standard curve produced with L-α-
phosphatidylcholine dissolved in chloroform (Sigma, St.
Louis, MO).
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